Prosecution Insights
Last updated: April 19, 2026

Examiner: OGUNTADE, ELIZABETH BISOLA

Tech Center 1600 • Art Units: 1600 1677

This examiner grants 0% of resolved cases

Performance Statistics

%
Allow Rate
-60.0% vs TC avg
12
Total Applications
+0.0%
Interview Lift
1175
Avg Prosecution Days
Based on 1 resolved cases, 2023–2026

Rejection Statute Breakdown

6.3%
§101 Eligibility
18.8%
§102 Novelty
36.3%
§103 Obviousness
28.8%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18015510 Methods For Detecting Biomolecules of Interest By Biolayer Interferometry Non-Final OA The Regents of the University of California
18552371 BIOLOGICAL SUBSTANCE DETECTION METHOD USING WELL ARRAY AND PARTICLES, WELL ARRAY, AND DETECTION DEVICE Non-Final OA NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY
18280706 ARTIFICIAL TARGET FOR ANTIGEN-SPECIFIC ACTIVATION AND EXPANSION OF CAR T CELLS Non-Final OA Miltenyi Biotec B.V. & Co KG
16975877 CHITINASE PROTEINS IN NEUROLOGIC DISEASE Non-Final OA Dignity Health
17730337 AUTOMATED FLUIDIC ASSAY BASED ON MOLECULARLY IMPRINTED POLYMER FOR DETECTION OF ANTIBODIES AND PROTEINS IN BODY FLUIDS Non-Final OA THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY
18371996 FIELD EFFECT TRANSISTOR SENSOR DETECTION ASSAYS AND SYSTEMS AND METHODS OF MAKING AND USING SAME Non-Final OA iNanoBio, Inc.
17923672 MEASUREMENT OF AFUCOSYLATED IGG FC GLYCANS AND RELATED COVID-19 TREATMENT METHODS Non-Final OA CZ BIOHUB SF, LLC
18372555 Development of a multiplexing Biosensing platform for the simultaneous detection of Snake and Scorpion venoms Non-Final OA Alfaisal University
18126108 DEVELOPMENT OF NOVEL APTAMER-BASED BIOSENSOR FOR DETECTION OF SARS-COV-2 PROTEIN IN NASOPHARYNGEAL SWABS OF COVID-19 PATIENTS Non-Final OA University of Sharjah
17781697 OPTICAL METHOD FOR DETECTING A TARGET MOLECULE BY MEANS OF THE AMPLIFICATION IN THE INTERFERENCE RESPONSE, RESULTING FROM THE REFRACTIVE INDEX AND DISPERSION Final Rejection BIO OPTICAL DETECTION, S.L.
17413368 MULTIPLEXED ASSAY Non-Final OA OSLER DIAGNOSTICS LIMITED

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month